← Leaderboards
Gita Shankar
Sri International
$2,430,268
Attributed
$2,571,737
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $842.3K · FY2012–17$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,571,737 · 5
By mechanism
R33$1,510,248 · 1
R21$506,497 · 1
N01$458,146 · 2
R03$96,846 · 1
Top collaborators
- Carsten Alt1 shared
Most similar at Sri International
Same institution · by research overlap
- Carol E Green$19,982,282
- Carsten Alt$141,469
- Michael Jay$1,925,583
Others in their field
Top investigators on “Absorption”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$82,226,988
- George R Painter · Chimerix, Inc.$36,309,505
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Mark Donowitz · Johns Hopkins University$26,452,142
- Ehud Isacoff · University Of California Berkeley$23,916,000
- Lihong Wang · Texas A&M University System$22,538,040
Research focus
AbsorptionResearch PersonnelClinical TrialsPre-ClinicalMicrobicidePolymersExhibitsDevelopment PlansFemaleEpithelial CellsBaseBiocompatible PolymerDrug KineticsDoseContraceptive AgentsEpitheliumCell Culture TechniquesCaviaCharacteristicsAcyclovirCondomsAntiviral AgentsCombined Modality TherapyBuffers
Grant awards (10)
Oral Radiation Nuclear Decorporation Agents$57,893
N01 · FY2017 · AI · contact PI
DEVELOP A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN FOR ACTIVITIES CONDUCTED UNDER TASK AREA D.$27,304
N01 · FY2017 · AI · contact PI
Combination Therapy using an Innovative Bioadhesive Polymeric Transmucosal Delive$486,474
R33 · FY2016 · AI · contact PI
Oral Radiation Nuclear Decorporation Agents$40,614
N01 · FY2016 · AI · contact PI
Combination Therapy using an Innovative Bioadhesive Polymeric Transmucosal Delive$509,947
R33 · FY2015 · AI · contact PI
Oral Radiation Nuclear Decorporation Agents$332,335
N01 · FY2015 · AI · contact PI
Combination Therapy using an Innovative Bioadhesive Polymeric Transmucosal Delive$513,827
R33 · FY2014 · AI · contact PI
Combination Therapy using an Innovative Bioadhesive Polymeric Transmucosal Delive$223,559
R21 · FY2013 · AI · contact PI
Combination Therapy using an Innovative Bioadhesive Polymeric Transmucosal Delive$282,938
R21 · FY2012 · AI · contact PI
NASAL ANTHRAX VACCINE DELIVERY FORMULATIONS$96,846
R03 · FY2004 · AI